SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of WellCare Health Plans, Inc – WCG

BALA CYNWYD, April 2, 2019 /Access Wire/ – Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of WellCare Health Plans, Inc (“WellCare” or “the Company”) (NYSE – WCG-News) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the sale of the Company to Centene Corporation. (“Centene”).

Under the terms of the transaction, WellCare shareholders will receive only $120 in cash and 3.38 shares of Centene stock for each share of WellCare stock they own. The transaction values WellCare at only approximately $305.39 per share. The investigation concerns whether the Board of WellCare breached their fiduciary duties to shareholders and whether Centene is underpaying for the Company. The transaction may undervalue the Company and may not be in the WellCare shareholders best interests. For example, shares of WellCare have traded at $320.49 per share and an analyst has set a $360.00 per target for WellCare stock.

If you own shares of Wellcare stock and wish to discuss the legal ramifications of  the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire, or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 510, Bala Cynwyd, PA  19004, or calling toll free 877-LEGAL-90.

Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.